Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd.

This study tests a new antibody drug (610) for adults with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal is to see if adding this drug to standard treatment improves lung function and reduces asthma attacks over 52 weeks…

This study tests a new medicine called 611 in 243 adults with chronic sinusitis and nasal polyps that haven't been well-controlled by other treatments. The goal is to see if 611 can shrink polyps and ease nasal congestion over 24 weeks. Participants receive either 611 or a placeb…

This study tests a new medicine called 611 in 124 children and teens (ages 6 to 17) with moderate to severe eczema. The goal is to see if it is safe and how well it works to reduce skin symptoms like redness and itching. Participants receive the drug as an injection, and research…